Andrzej Gamian

Prof. Gamian graduated from the Faculty of Natural Sciences at the University of Wroclaw in 1975 and he started to work at the Hirszfeld Institute of Immunology and Experimental Therapy, PAS where he carried out his doctoral studies on the immunochemistry of Shigella lipopolysaccharides and obtained his PhD in 1982. Between 1984-86 he joined a research group at the National Research Council of Canada in Ottawa, where he was working on the development of anti-meningococcal B meningitis vaccine. In 1990 he was a scholar at the CNRS in Grenoble, France, working on the structure of the sugar part of the endotoxins. He was also involved in the research on bacterial antigens at the Arrhenius Laboratory in Stockholm and Uppsala. In 1993 he received his habilitation for the work on the Enterobacteriaceae lipopolysaccharides containing sialic acid, and ten years later was nominated full professor by the President of the Republic of Poland. Since 1994 has been the head of the Department of Immunology of Infectious Diseases, HIIET PAS. Between 2006-2020 he was also the head of the Department of Medical Biochemistry, Medical University in Wroclaw. Since July 2020 has been the Director of the HIIET, PAS in Wroclaw. He has co-authored over 380 scientific publications and is the owner of 50 patents and patent applications. His scientific interests focus mainly on the study of polysaccharides immunochemistry, the study of glycolipids, microbial proteins, and phages, and their utility in diagnostics, antiviral and antibacterial vaccine design and clinical therapy. His most significant scientific interests are focused on the issue of protein glycation and the consequences of AGEs aggregation in the body. In addition, his expertise includes methods of determining disease markers, especially metabolic, vascular, and neurodegenerative diseases.